Cardiol Therapeutics (CRDL) Competitors C$1.51 -0.05 (-3.21%) As of 08/28/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock CRDL vs. DNA, VBV, CUS, AIM, ITH, FRX, IPA, APM, GXE, and MDNAShould you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Dalradian Resources (DNA), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), International Tower Hill Mines (ITH), Fennec Pharmaceuticals (FRX), ImmunoPrecise Antibodies (IPA), Andean Precious Metals (APM), Gear Energy (GXE), and Medicenna Therapeutics (MDNA). These companies are all part of the "pharmaceutical products" industry. Cardiol Therapeutics vs. Its Competitors Dalradian Resources VBI Vaccines Chemtrade Electrochem Inc, Aimia International Tower Hill Mines Fennec Pharmaceuticals ImmunoPrecise Antibodies Andean Precious Metals Gear Energy Medicenna Therapeutics Cardiol Therapeutics (TSE:CRDL) and Dalradian Resources (TSE:DNA) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment. Does the media refer more to CRDL or DNA? In the previous week, Cardiol Therapeutics' average media sentiment score of 0.00 equaled Dalradian Resources'average media sentiment score. Company Overall Sentiment Cardiol Therapeutics Neutral Dalradian Resources Neutral Which has preferable earnings & valuation, CRDL or DNA? Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Dalradian Resources, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-2.97Dalradian ResourcesN/AN/AN/A-C$0.03N/A Do institutionals & insiders have more ownership in CRDL or DNA? 11.4% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is CRDL or DNA more profitable? Dalradian Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cardiol TherapeuticsN/A -195.07% -54.15% Dalradian Resources N/A N/A N/A SummaryCardiol Therapeutics and Dalradian Resources tied by winning 3 of the 6 factors compared between the two stocks. Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRDL vs. The Competition Export to ExcelMetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$125.30MC$2.21BC$5.78BC$6.40BDividend YieldN/A2.92%3.95%6.72%P/E Ratio-2.974.3131.2766.88Price / SalesN/A623.63429.141,650.19Price / Cash0.9810.3737.7383.29Price / Book10.1111.5510.195.33Net Income-C$42.93MC$20.70BC$3.27BC$301.20M7 Day Performance-6.79%0.99%1.37%2.61%1 Month Performance-24.88%5.54%6.17%4.83%1 Year Performance-41.47%5.27%43.98%32.34% Cardiol Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRDLCardiol TherapeuticsN/AC$1.51-3.2%N/A-41.7%C$125.30MN/A-2.9720High Trading VolumeDNADalradian ResourcesN/AN/AN/AN/AC$519.02MN/A-56.15640VBVVBI VaccinesN/AN/AN/AN/AC$308.86MC$3.36M-4.9722CUSChemtrade Electrochem Inc,N/AN/AN/AN/AC$306.50MN/A0.0060AIMAimia1.7213 of 5 starsC$3.12-1.3%C$4.00+28.2%+23.2%C$300.07MC$464.71M-3.8420ITHInternational Tower Hill MinesN/AC$1.85-0.5%N/A+162.5%C$259.73MN/A-77.29220Gap DownFRXFennec PharmaceuticalsN/AC$12.01-1.2%N/A+63.0%C$231.61MC$34.86M-203.4510IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownAPMAndean Precious Metals2.4099 of 5 starsC$1.29+7.5%C$2.00+55.0%+22.9%C$135.47MC$154.78M2.5530GXEGear EnergyN/AN/AN/AN/AC$126.52MC$134.93M10.391,310MDNAMedicenna TherapeuticsN/AC$1.10-1.8%N/A-49.3%C$82.30MC$4.87K-3.0320 Related Companies and Tools Related Companies Dalradian Resources Alternatives VBI Vaccines Alternatives Chemtrade Electrochem Inc, Alternatives Aimia Alternatives International Tower Hill Mines Alternatives Fennec Pharmaceuticals Alternatives ImmunoPrecise Antibodies Alternatives Andean Precious Metals Alternatives Gear Energy Alternatives Medicenna Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRDL) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access